Oppenheimer & Co’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Oppenheimer & Co’s Portfolio NXGN Stock Details NXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-29,069	Closed	-$329K	–	1363
2016 Q3	$329K	Sell	29,069 -1,800	-6%	-$21.6K	0.01%	954
2016 Q2	$368K	Sell	30,869 -3,761	-11%	-$50.6K	0.01%	896
2016 Q1	$528K	Buy	34,630 +439	+1%	+$6.66K	0.02%	732
2015 Q4	$551K	Sell	34,191 -19,950	-37%	-$291K	0.02%	734
2015 Q3	$676K	Sell	54,141 -47,386	-47%	-$651K	0.02%	702
2015 Q2	$1.68M	Sell	101,527 -44,673	-31%	-$720K	0.05%	459
2015 Q1	$2.34M	Buy	+146,200	New	+$2.42M	0.06%	352

Other funds holding NXGN

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oppenheimer & Co's NXGN Position: Q4 2016 in Review

Oppenheimer & Co sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2016, closing a stake of 29,069 shares — an estimated $329K sold.

Oppenheimer & Co first reported a position in NXGN in Q1 2015 and held it in 7 quarters. The position peaked at $2.34M in Q1 2015. 184 funds tracked by Wall St. Rank hold NXGN as of Q4 2016.

Oppenheimer & Co reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Oppenheimer & Co sold 29,069 NextGen Healthcare, Inc. Common Stock shares in Q4 2016, an estimated $329K.
Oppenheimer & Co first reported a position in NextGen Healthcare, Inc. Common Stock in Q1 2015 and held it in 7 quarters.
Oppenheimer & Co's NextGen Healthcare, Inc. Common Stock position peaked at $2.34M in Q1 2015.
184 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2016.

Based on Oppenheimer & Co's 13F filing for Q4 2016, filed 2 Feb 2017.